Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysisDarren R Feldman, Joel Sheinfeld, Dean F Bajorin, et al.
Plos One|February 15, 2019
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of responseCaitlin Murphy, Andrea Muscat, David Ashley, et al.
European Journal of Radiology|August 10, 2016
Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancerManuela Durando, Lucas Gennaro, Gene Y Cho, et al.
Gynecologic Oncology|June 28, 2015
Development of a risk stratification system to guide treatment for female germ cell tumorsJane L Meisel, Kaitlin M Woo, Nora Sudarsan, et al.
The Oncologist|March 18, 2016
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast CancerAnthony F Yu, Carlos Manrique, Shawn Pun, et al.
Clinical Genitourinary Cancer|September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted DrugsChung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatmentGeorge A Poultsides, Elliot L Servais, Leonard B Saltz, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
The Oncologist|June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Ana M Molina, Yulia Lakhman, et al.
Diseases of the Colon and Rectum|December 11, 2020
Primary Tumor-Related Complications and Salvage Outcomes in Patients with Metastatic Rectal Cancer and an Untreated Primary TumorWinson J Tan, Sujata Patil, Jose G Guillem, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysisDarren R Feldman, Joel Sheinfeld, Dean F Bajorin, et al.
Plos One|February 15, 2019
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of responseCaitlin Murphy, Andrea Muscat, David Ashley, et al.
European Journal of Radiology|August 10, 2016
Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancerManuela Durando, Lucas Gennaro, Gene Y Cho, et al.
Gynecologic Oncology|June 28, 2015
Development of a risk stratification system to guide treatment for female germ cell tumorsJane L Meisel, Kaitlin M Woo, Nora Sudarsan, et al.
The Oncologist|March 18, 2016
Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast CancerAnthony F Yu, Carlos Manrique, Shawn Pun, et al.
Clinical Genitourinary Cancer|September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted DrugsChung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatmentGeorge A Poultsides, Elliot L Servais, Leonard B Saltz, et al.
Cancer|November 21, 2012
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancerSusan M Domchek, Komal Jhaveri, Sujata Patil, et al.
The Oncologist|June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Ana M Molina, Yulia Lakhman, et al.
Diseases of the Colon and Rectum|December 11, 2020
Primary Tumor-Related Complications and Salvage Outcomes in Patients with Metastatic Rectal Cancer and an Untreated Primary TumorWinson J Tan, Sujata Patil, Jose G Guillem, et al.
Pageof 23